Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04939935 |
| Consolidated Lead Sponsor | The University of Queensland |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 1,174 participants (ESTIMATED) |
| Registered Start Date | 2022-11-29 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Royal Brisbane and Women's Hospital | Herston, Australia | Open Hospital Dossier -> |
| Princess Alexandra Hospital | Woolloongabba, Australia | Open Hospital Dossier -> |
| Royal Adelaide Hospital | Adelaide, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.